Clinical Epidemiology & Biostatistics



Mark Oremus

BA (McGill), MA (Concordia), MSc (McGill), PhD (McGill)

McLaughlin Foundation Professor of Population and Public Health & Assistant Professor,
Department of Clinical Epidemiology & Biostatistics

Associate Scientific Director, Canadian Longitudinal Study on Aging

905.525.9140 x22437
905.522.7681
oremusm@mcmaster.ca

McMaster University
DTC Building, Room 308
1280 Main Street West
Hamilton, ON, Canada,
L8S 4L8

Office Location: Downtown Centre
50 Main Street East, Room 308
Hamilton, Ontario, Canada, L8N 1E9

Administrative Assistant: Leah Macdonald
905.525.9140 x22882
905.522.7681
lmacdon@mcmaster.ca

Academic Interests

Population and public health, aging, dementia, caregiving, knowledge transfer, questionnaire design and administration, systematic reviews, measuring drug efficacy, health economics, health policy.

Selected Publications

  1. Oremus M, Tarride JE. Modeling cost-effectiveness of pharmaceuticals in Alzheimer’s disease. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):275-277.
  2. Oremus M, Oremus C, Hall GB, McKinnon MC; ECT & Cognition Systematic Review Team. Inter-rater and test-retest reliability of quality assessments by novice student raters using the Jadad and Newcastle-Ottawa Scales. BMJ Open. 2012;2(4): doi: 10.1136/bmjopen-2012-001368.
  3. Oremus M, Santaguida P, Walker K, Wishart LR, Siegel KL, Raina P. Studies of stroke rehabilitation therapies should report blinding and rationalize use of outcome measurement instruments. J Clin Epidemiol. 2012;65(4):368-374.
  4. Oremus M, Dayes I, Walker K, Raina P. Systematic review: conservative treatments for secondary lymphedema. BMC Cancer. 2012;12(1):6.
  5. Xie F, Oremus M, Gaebel K. Measuring health-related quality-of-life for Alzheimer’s disease using the general public. Qual Life Res. 2012;21(4):593-601.
  6. Tarride JE, Oremus M, Pullenayegum E, Clayton N, Raina P. How does the Canadian general public rate moderate Alzheimer's disease? J Aging Res. 2011;doi:10.4061/2011/682470.
  7. Oremus M, Aguilar SC. A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada. Pharmacoeconomics. 2011;29(2):141-156.
  8. Oremus M, Tarride JE. An economic evaluation of surgery versus collagen injection for the treatment of female stress urinary incontinence. Can J Urol. 2010;17(2):5087-5093.
  9. Oremus M, Raina P, Eva K, Lavis JN, Nair K, Lo A, Smith S.  Impact of clinician judgment on formulary committees' recommendations in Canada. J Health Serv Res Policy. 2010;15(2):98-105.
  10. Oremus M, Tarride JE, Clayton, N, Raina P. Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada. BMC Health Serv Res. 2009;9(1):246 - doi:10.1186/1472-6963-9-246.

Search for citations for Dr. Oremus on PubMed